GleamWall
中文EN

LIFD LFTD PARTNERS INC.

Pharmaceutical Preparations · OTC · SEC CIK 1391135 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-15.9%
TTM net income YoY-53,461.9%
TTM EPS YoY—
Revenue 3-yr CAGR-14.3%
Net income 3-yr CAGR—

Margins

Gross margin8.3%
Operating margin-27.9%
Net margin-108.9%
FCF margin2.1%
EBITDA margin-26.8%

Returns

ROE-164.2%
ROA-127.1%
ROIC (approx.)-38.3%
Asset turnover1.17x

Leverage & solvency

Liabilities / assets55.7%
Debt / equity0.00x
Current ratio1.63x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.02x
Accruals ratio-130.2%
Payout ratio—
Capex / revenue0.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$4.81M$8.71M$9.16M$8.41M$9.06M$10.33M$9.12M$8.48M
Cost of revenue$4.17M$8.05M$10.86M$5.42M$4.90M$7.08M$6.91M$6.42M
Gross profit$641,858$651,233-$1.71M$3.00M$4.16M$3.25M$2.22M$2.06M
Operating income-$2.63M-$1.53M-$4.57M$38,443$1.31M-$109,640-$328,386$72,318
Interest expense$20,837$21,760$21,216—$73,481$77,474$79,993—
Pretax income-$2.52M-$1.64M-$4.72M-$24.59M$870,814-$323,778-$382,750$3,924
Income tax$817,139-$206,662-$555,148$330,803$236,557-$54,828-$79,708$2,738
Net income-$3.34M-$1.44M-$4.16M-$24.92M$634,257-$268,950-$303,042$1,186
EBITDA-$2.61M-$1.48M-$4.43M$175,124$1.37M-$47,128-$188,754$208,670
EPS (basic)-0.23-0.10-0.28—0.04-0.02-0.02—
EPS (diluted)-0.23-0.10-0.28—0.04-0.02-0.02—
Weighted avg. shares (diluted)14.82M14.82M14.82M—14.96M14.82M14.82M—
Banking
Deposits———$1.00M——$1.00M$1.00M
Balance sheet
Cash & equivalents$2.49M$1.50M$2.09M$1.77M$2.92M$3.12M$3.28M$3.15M
Receivables$1.84M$2.92M$2.25M$2.53M$2.31M$4.01M$2.99M$2.66M
Inventory$2.36M$3.46M$5.53M$10.96M$10.08M$9.66M$9.79M$9.32M
Current assets$6.80M$9.38M$10.26M$15.69M$14.59M$17.88M$17.42M$17.23M
PP&E, net$598,017$643,021$2.10M$2.27M$2.38M$2.51M$2.64M$2.70M
Goodwill———$0$23.09M$23.09M$23.09M$23.09M
Intangibles$5,023——$0————
Total assets$8.32M$12.03M$14.45M$19.27M$44.94M$48.08M$47.76M$47.62M
Current liabilities$4.17M$3.65M$4.54M$5.16M$4.83M$7.60M$7.04M$6.39M
Total liabilities$4.64M$5.00M$5.98M$6.64M$7.39M$11.16M$10.56M$10.12M
Shareholders' equity$3.68M$7.03M$8.47M$12.63M$37.56M$36.93M$37.20M$37.50M
Shares outstanding14.82M14.82M14.82M14.82M14.82M14.82M14.82M14.82M
Cash flow statement
Operating cash flow$374,224-$554,945$458,860$536,315$699,045-$265,608$351,751-$892,913
Capital expenditure-$13,966$19,316$119,682$34,557$2,531$7,404$77,147$3,000
Free cash flow$388,190-$574,261$339,178$501,758$696,514-$273,012$274,604-$895,913
Investing cash flow$1.46M-$19,316-$119,682-$34,557-$2,531-$7,404-$77,147$1,037
Financing cash flow-$849,980-$12,572-$15,171-$1.66M-$891,902$109,103-$141,590-$135,982
Depreciation & amortization$22,299$47,047$139,272$136,681$62,161$62,512$139,632$136,352
Share buybacks———$0$0——$0

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.